PRO MEDICUS LTD (PME.AU) experienced a significant intraday surge, with its stock price soaring 5.13% during Thursday's trading session.
The sharp upward movement appears to be driven by positive corporate developments. According to recent reports, co-founders and directors of Pro Medicus purchased A$3.4 million worth of shares on the market, signaling strong insider confidence in the company's prospects. Additionally, investors are showing increased interest ahead of the company's interim dividend payment scheduled for March 20.
These developments come amid discussions about the company's valuation, with some narratives suggesting the stock may be trading at a discount to its fair value, potentially contributing to renewed investor optimism.